This federal contract award, valued at $2,510.64, was issued by the Medical Supply Chain division of the Department of Defense to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of APOLLORF XL90 Aspirating Ablator 90 devices and was awarded on December 23, 2024, with a completion date of December 27, 2024. The contract has a fixed price with economic price adjustment pricing type and is not designated as a set-aside contract.
Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $471,048,172.66, which allows VA medical centers nationwide to acquire the company's innovative orthopedic technologies through task orders. Arthrex has a robust portfolio of federal contract awards for specialized orthopedic solutions, including surgical implants, arthroscopic instruments, joint replacement technologies, and other advanced medical products tailored to meet the needs of government healthcare systems, particularly the Department of Veterans Affairs and the Department of Defense.
Generated 3/24/25, 9:54 AM